Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of pulsatile dexamethasone therapy in childhood epilepsy on the immune system
2016-002658-19Phase 4Completed
- Sponsor
- Department of Pediatrics I, Medical University of Innsbruck
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone in West syndrome, Lennox-Gastaut syndrome (LGS), developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS) and 1 more (2 arms), sponsored by Department of Pediatrics I, Medical University of Innsbruck. Primary endpoint: End of treatment interval. Started May 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
West syndromeLennox-Gastaut syndrome (LGS)developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS)Continuous spike-and-wave during sleep syndrome (CSWS)
Beyond the preview
Go deeper on 2016-002658-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002658-19.